Idarucizumab

Definition: Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran. Idarucizumab was developed by Boehringer Ingelheim. source: Wikipedia

ID

716017002

ID date

18 Nov 2016

Previous ID

31088611000001108

Name

Idarucizumab